Clinical trial

A Study of Hyaluronan for the Treatment of Osteoarthritis in the Thumb

NCT00398866 · Hospital for Special Surgery, New York, Other · Completed

Key facts

NCT number NCT00398866
Title A Study of Hyaluronan for the Treatment of Osteoarthritis in the Thumb
Official title A Study of Hyaluronan (Synvisc) for the Treatment of Osteoarthritis in the Thumb: Randomized Control Trial
Lead sponsor Hospital for Special Surgery, New York, Other
Collaborators National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH Genzyme, a Sanofi Company Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Osteoarthritis
Intervention type Drug
Interventions Synvisc (Hylan G-F20, hyaluronan injection), Bupivicaine (local anesthesia injection), Kenalog (triamcinolone, corticosteroid injection)
Enrollment 200
Start date Aug 1, 2006
Primary completion Mar 1, 2013
Completion Mar 1, 2013
First posted Nov 14, 2006
Last update posted Jul 7, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies